comparemela.com

Latest Breaking News On - Wayne lautt - Page 2 : comparemela.com

Head to Head Contrast: DiaMedica Therapeutics (NASDAQ:DMAC) and 9 Meters Biopharma (NASDAQ:NMTR)

DiaMedica Therapeutics (NASDAQ:DMAC – Get Rating) and 9 Meters Biopharma (NASDAQ:NMTR – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, profitability, risk, analyst recommendations, dividends, valuation and institutional ownership. Analyst Ratings This is a breakdown of current […]

Financial Review: DiaMedica Therapeutics (NASDAQ:DMAC) and Marinus Pharmaceuticals (NASDAQ:MRNS)

Marinus Pharmaceuticals (NASDAQ:MRNS – Get Rating) and DiaMedica Therapeutics (NASDAQ:DMAC – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, profitability, dividends, analyst recommendations, risk, earnings and institutional ownership. Analyst Ratings This is a breakdown of current ratings […]

Analyzing 9 Meters Biopharma (NASDAQ:NMTR) and DiaMedica Therapeutics (NASDAQ:DMAC)

DiaMedica Therapeutics (NASDAQ:DMAC – Get Rating) and 9 Meters Biopharma (NASDAQ:NMTR – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, profitability, risk, earnings, analyst recommendations, dividends and valuation. Volatility & Risk DiaMedica Therapeutics has a beta […]

DiaMedica Therapeutics Inc (NASDAQ:DMAC) Short Interest Up 55 6% in March

DiaMedica Therapeutics Inc. (NASDAQ:DMAC – Get Rating) was the recipient of a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 91,500 shares, an increase of 55.6% from the March 15th total of 58,800 shares. Based on an average daily trading volume, of 31,800 shares, […]

DiaMedica Therapeutics Inc (NASDAQ:DMAC) Insider David J Wambeke Purchases 468,750 Shares

DiaMedica Therapeutics Inc. (NASDAQ:DMAC – Get Rating) insider David J. Wambeke purchased 468,750 shares of the company’s stock in a transaction dated Monday, April 10th. The stock was acquired at an average price of $1.60 per share, with a total value of $750,000.00. Following the completion of the transaction, the insider now owns 468,750 shares […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.